Raittinen, Paavo
Niemistö, Kati
Pennanen, Erika
Syvälä, Heimo
Auriola, Seppo
Riikonen, Jarno
Lehtimäki, Terho
Ilmonen, Pauliina
Murtola, Teemu
Funding for this research was provided by:
Tays (25024194)
Academy of Finland (322098 and 286284)
Article History
Received: 4 December 2019
Accepted: 29 June 2020
First Online: 21 July 2020
Competing interests
: Conflict of interest statement: 1. Dr. Jarno Riikonen receives reimbursements for travel and conferences from Swanmedica, Astellas, and Ferring and trialparticipation from Astellas, Pfizer, Bayer, Orion, and Myovant 2. Dr. Teemu Murtola conflict of interest: Paid consultancy for Astellas, Ferring, Janssen. Speaker's honorarium from Astellas, Janssen, Sanofi. Scientific meeting participation at expense of Ferring, Sanofi, Pfizer. No other conflict of interests